• Latest Posts

ASPIRE set up to collaborate on amyloidosis

Spinoff Biohaven launches with $258M and “incredible pipeline”

CytoReason and Pfizer agree deal worth up to $110M for AI drug discovery and development

Moderna to sue Pfizer and German partner, BioNTech, for allegedly “copying technology”

Cancer therapeutics company’s double win with $25M funding, and appointment of new board member

In Depth 4 Jul 2022

The COVID-19 pandemic has driven RNA therapeutics into the mainstream


Sirana Pharma and Pfizer to work on treatment for brittle bone disease

Global call for scientists and inventors to form new startup

Next-Gen Covid-19 Vaccines and Drugs Crowd into Late-Stage Trials

Big Pharma Strikes Megadeals In Targeted Protein Degradation

In Depth 11 Oct 2021

A Cure for Cancer? How CAR-T Cell Therapy is Revolutionizing Oncology